ExeVir Bio Overview
Company Headquarters: Ghent, Belgium
Founded: 2020
Workforce: ~10
Company Working: ExeVir Bio is a clinical-stage company that is developing novel antibody therapies that are used in the treatment of infectious diseases. The company is utilizing highly innovative and clinically supported VHH technology to develop a treatment for viral infections. ExeVir cooperates closely with Belgium’s leading life sciences research institute VIB, developing new VHH antibodies together with the laboratories. The company has a strong distribution network in the Asia-Pacific region.



